Zone7, AI Company Which Predicts Injury Among Athletes Raises $2.5 Million Seed Investment


Palo Alto, California-based AI startup Zone7 that predicts the injury threats among the athletes has secured $2.5 million in a seed round investment. Seed stage investor Resolute Ventures led the funding round for the firm along with participation from PLG Ventures, UpWest Labs, Amicus Capital, and Arba Seed Investment Group's managing partner Deve Pell. National Basketball Association player Kristaps Porzingis also invested through the round.

The company uses data and analytics from wearable devices, medical profiles, and physio & screening products in order to deliver an accurate result. Using those results, the platform also tells the athletes the plan of action in order to get the potential injury problem curbed. The company also uses past performances and medical history for the course of action which would make sure that the player or athlete is not having an injury risk. The company claims to have an accuracy of more than 95% in their prediction and that has reduced the potential of injury by 75%. Founded in 2017 by Eyal Eliakim, and Tal Brown, the platform as per the company statement has been used by teams like MLB, La Liga, Champions League, MLS, collegiate athletic departments and Olympic teams.

Zone7 LogoBrown, the CEO of Zone7 commenting about the firm said, “Injuries in professional sports cost billions annually, but in the era of big data it doesn’t have to be that way. Professional sports franchises have massive amounts of untapped health and performance data that, when unlocked by AI, can become one of a team’s most valuable assets. By better understanding every athlete’s breaking points and implementing personalized intervention plans to prevent injuries before they occur, teams no longer have to accept injuries as an inevitability.”

Raanan Bar-Cohen, Resolute Ventures' general partner in a statement said, “Professional sports are, for the most part, slow to embrace medical and performance data, and as such, this has historically been a difficult target market to break into. Tal and Eyal have built a compelling product that is making teams stand up and take notice. It’s literally a game changer. The fact that Zone7 is the first company to show injuries can be avoided by using artificial intelligence makes us extremely excited to partner with the Zone7 team.”


Image Courtesy : Zone7

Add new comment

About Author